US Stock MarketDetailed Quotes

UCBB US-CHINA BIOMEDICAL TECHNOLOGY INC

Watchlist

0.000
0.0000.00%

15min DelayClose Jul 12 09:30 ET

0Market Cap0.00P/E (TTM)

US-CHINA BIOMEDICAL TECHNOLOGY INC Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)May 31, 2019

(FY)Feb 28, 2019

(Q4)Feb 28, 2019

(Q3)Nov 30, 2018

(Q2)Aug 31, 2018

(Q1)May 31, 2018

(FY)Feb 28, 2018

(Q4)Feb 28, 2018

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

11.11%-108.2K

-35.87%-544.67K

1.64%-174.94K

-128.69K

-119.3K

-121.73K

-400.89K

-177.86K

Net income from continuing operations

55.32%-122.7K

-47.45%-710.94K

-129.84%-173.98K

---119.35K

---142.97K

---274.65K

---482.16K

---75.7K

Operating gains losses

----

509.24%184.16K

--0

--184.16K

---45K

----

Other non cash items

-53.49%1.81K

-95.18%3.9K

----

--3.9K

--80.84K

----

Change In working capital

136.10%12.69K

-148.12%-21.78K

96.48%-4.86K

---9.35K

--27.56K

---35.14K

--45.26K

---138K

-Change in prepaid assets

171.14%9.03K

22.99%-16.73K

31.79%-13.11K

--4.24K

--4.84K

---12.7K

---21.72K

---19.22K

-Change in payables and accrued expense

116.28%3.65K

-119.74%-13.22K

105.67%6.74K

---15.81K

--18.29K

---22.44K

--66.98K

---118.78K

-Change in other working capital

----

--8.17K

--1.52K

--2.22K

----

Cash from discontinued investing activities

Operating cash flow

11.11%-108.2K

-35.87%-544.67K

1.64%-174.94K

---128.69K

---119.3K

---121.73K

---400.89K

---177.86K

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

-59.22%213.99K

15.61%524.81K

524.81K

453.93K

234.26K

Net issuance payments of debt

211.11%50K

-111.88%-45K

--0

---45K

--378.93K

--234.26K

Net common stock issuance

-71.22%163.99K

659.74%569.81K

--0

--569.81K

--75K

--0

Cash from discontinued financing activities

Financing cash flow

-59.22%213.99K

15.61%524.81K

--0

--524.81K

--453.93K

--234.26K

Net cash flow

Beginning cash position

-35.22%36.54K

1,575.79%56.41K

3,524,616.67%211.48K

--340.18K

--459.48K

--56.41K

--3.37K

--6

Current changes in cash

-73.75%105.79K

-137.45%-19.87K

-410.17%-174.94K

---128.69K

---119.3K

--403.07K

--53.04K

--56.4K

End cash Position

-69.02%142.33K

-35.22%36.54K

--211.48K

--340.18K

--459.48K

--56.41K

Free cash flow

11.11%-108.2K

-35.87%-544.67K

1.64%-174.94K

---128.69K

---119.3K

---121.73K

---400.89K

---177.86K

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)May 31, 2019	(FY)Feb 28, 2019	(Q4)Feb 28, 2019	(Q3)Nov 30, 2018	(Q2)Aug 31, 2018	(Q1)May 31, 2018	(FY)Feb 28, 2018	(Q4)Feb 28, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	11.11%-108.2K	-35.87%-544.67K	1.64%-174.94K	-128.69K	-119.3K	-121.73K	-400.89K	-177.86K
Net income from continuing operations	55.32%-122.7K	-47.45%-710.94K	-129.84%-173.98K	---119.35K	---142.97K	---274.65K	---482.16K	---75.7K
Operating gains losses	----	509.24%184.16K	--0	--0	--0	--184.16K	---45K	----
Other non cash items	-53.49%1.81K	-95.18%3.9K	----	----	----	--3.9K	--80.84K	----
Change In working capital	136.10%12.69K	-148.12%-21.78K	96.48%-4.86K	---9.35K	--27.56K	---35.14K	--45.26K	---138K
-Change in prepaid assets	171.14%9.03K	22.99%-16.73K	31.79%-13.11K	--4.24K	--4.84K	---12.7K	---21.72K	---19.22K
-Change in payables and accrued expense	116.28%3.65K	-119.74%-13.22K	105.67%6.74K	---15.81K	--18.29K	---22.44K	--66.98K	---118.78K
-Change in other working capital	----	--8.17K	--1.52K	--2.22K	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	11.11%-108.2K	-35.87%-544.67K	1.64%-174.94K	---128.69K	---119.3K	---121.73K	---400.89K	---177.86K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities	-59.22%213.99K	15.61%524.81K	0	0	0	524.81K	453.93K	234.26K
Net issuance payments of debt	211.11%50K	-111.88%-45K	--0	--0	--0	---45K	--378.93K	--234.26K
Net common stock issuance	-71.22%163.99K	659.74%569.81K	--0	--0	--0	--569.81K	--75K	--0
Cash from discontinued financing activities
Financing cash flow	-59.22%213.99K	15.61%524.81K	--0	--0	--0	--524.81K	--453.93K	--234.26K
Net cash flow
Beginning cash position	-35.22%36.54K	1,575.79%56.41K	3,524,616.67%211.48K	--340.18K	--459.48K	--56.41K	--3.37K	--6
Current changes in cash	-73.75%105.79K	-137.45%-19.87K	-410.17%-174.94K	---128.69K	---119.3K	--403.07K	--53.04K	--56.4K
End cash Position	-69.02%142.33K	-35.22%36.54K	-35.22%36.54K	--211.48K	--340.18K	--459.48K	--56.41K	--56.41K
Free cash flow	11.11%-108.2K	-35.87%-544.67K	1.64%-174.94K	---128.69K	---119.3K	---121.73K	---400.89K	---177.86K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall